AUROBINDO PHARMA LTD.

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & DrugsHouse : Aurobindo
BSE1092.158.55 (+0.79 %)
PREV CLOSE ( ) 1083.60
OPEN PRICE ( ) 1080.00
BID PRICE (QTY) 1091.80 (38)
OFFER PRICE (QTY) 1093.00 (3)
VOLUME 8885
TODAY'S LOW / HIGH ( )1079.75 1095.30
52 WK LOW / HIGH ( )581.5 1177
NSE1092.708.65 (+0.8 %)
PREV CLOSE( ) 1084.05
OPEN PRICE ( ) 1081.05
BID PRICE (QTY) 1092.70 (2)
OFFER PRICE (QTY) 1092.75 (80)
VOLUME 861999
TODAY'S LOW / HIGH( ) 1079.10 1095.90
52 WK LOW / HIGH ( )581.25 1177.1

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.